Table of Content

1 Study Coverage
1.1 Antiretroviral Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Antiretroviral Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 NNRTIs
1.2.3 NRTI
1.2.4 Multiclass Combination Products
1.2.5 Integrase Inhibitors
1.3 Market by Application
1.3.1 Global Antiretroviral Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Antiretroviral Therapy Sales Estimates and Forecasts 2018-2029
2.2 Global Antiretroviral Therapy Revenue by Region
2.2.1 Global Antiretroviral Therapy Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Antiretroviral Therapy Revenue by Region (2018-2024)
2.2.3 Global Antiretroviral Therapy Revenue by Region (2024-2029)
2.2.4 Global Antiretroviral Therapy Revenue Market Share by Region (2018-2029)
2.3 Global Antiretroviral Therapy Sales Estimates and Forecasts 2018-2029
2.4 Global Antiretroviral Therapy Sales by Region
2.4.1 Global Antiretroviral Therapy Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Antiretroviral Therapy Sales by Region (2018-2024)
2.4.3 Global Antiretroviral Therapy Sales by Region (2024-2029)
2.4.4 Global Antiretroviral Therapy Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Antiretroviral Therapy Sales by Manufacturers
3.1.1 Global Antiretroviral Therapy Sales by Manufacturers (2018-2024)
3.1.2 Global Antiretroviral Therapy Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antiretroviral Therapy in 2022
3.2 Global Antiretroviral Therapy Revenue by Manufacturers
3.2.1 Global Antiretroviral Therapy Revenue by Manufacturers (2018-2024)
3.2.2 Global Antiretroviral Therapy Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Antiretroviral Therapy Revenue in 2022
3.3 Global Key Players of Antiretroviral Therapy, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Antiretroviral Therapy Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Antiretroviral Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Antiretroviral Therapy, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Antiretroviral Therapy, Product Offered and Application
3.8 Global Key Manufacturers of Antiretroviral Therapy, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antiretroviral Therapy Sales by Type
4.1.1 Global Antiretroviral Therapy Historical Sales by Type (2018-2024)
4.1.2 Global Antiretroviral Therapy Forecasted Sales by Type (2024-2029)
4.1.3 Global Antiretroviral Therapy Sales Market Share by Type (2018-2029)
4.2 Global Antiretroviral Therapy Revenue by Type
4.2.1 Global Antiretroviral Therapy Historical Revenue by Type (2018-2024)
4.2.2 Global Antiretroviral Therapy Forecasted Revenue by Type (2024-2029)
4.2.3 Global Antiretroviral Therapy Revenue Market Share by Type (2018-2029)
4.3 Global Antiretroviral Therapy Price by Type
4.3.1 Global Antiretroviral Therapy Price by Type (2018-2024)
4.3.2 Global Antiretroviral Therapy Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Antiretroviral Therapy Sales by Application
5.1.1 Global Antiretroviral Therapy Historical Sales by Application (2018-2024)
5.1.2 Global Antiretroviral Therapy Forecasted Sales by Application (2024-2029)
5.1.3 Global Antiretroviral Therapy Sales Market Share by Application (2018-2029)
5.2 Global Antiretroviral Therapy Revenue by Application
5.2.1 Global Antiretroviral Therapy Historical Revenue by Application (2018-2024)
5.2.2 Global Antiretroviral Therapy Forecasted Revenue by Application (2024-2029)
5.2.3 Global Antiretroviral Therapy Revenue Market Share by Application (2018-2029)
5.3 Global Antiretroviral Therapy Price by Application
5.3.1 Global Antiretroviral Therapy Price by Application (2018-2024)
5.3.2 Global Antiretroviral Therapy Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Antiretroviral Therapy Market Size by Type
6.1.1 US & Canada Antiretroviral Therapy Sales by Type (2018-2029)
6.1.2 US & Canada Antiretroviral Therapy Revenue by Type (2018-2029)
6.2 US & Canada Antiretroviral Therapy Market Size by Application
6.2.1 US & Canada Antiretroviral Therapy Sales by Application (2018-2029)
6.2.2 US & Canada Antiretroviral Therapy Revenue by Application (2018-2029)
6.3 US & Canada Antiretroviral Therapy Market Size by Country
6.3.1 US & Canada Antiretroviral Therapy Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Antiretroviral Therapy Sales by Country (2018-2029)
6.3.3 US & Canada Antiretroviral Therapy Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Antiretroviral Therapy Market Size by Type
7.1.1 Europe Antiretroviral Therapy Sales by Type (2018-2029)
7.1.2 Europe Antiretroviral Therapy Revenue by Type (2018-2029)
7.2 Europe Antiretroviral Therapy Market Size by Application
7.2.1 Europe Antiretroviral Therapy Sales by Application (2018-2029)
7.2.2 Europe Antiretroviral Therapy Revenue by Application (2018-2029)
7.3 Europe Antiretroviral Therapy Market Size by Country
7.3.1 Europe Antiretroviral Therapy Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Antiretroviral Therapy Sales by Country (2018-2029)
7.3.3 Europe Antiretroviral Therapy Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Antiretroviral Therapy Market Size
8.1.1 China Antiretroviral Therapy Sales (2018-2029)
8.1.2 China Antiretroviral Therapy Revenue (2018-2029)
8.2 China Antiretroviral Therapy Market Size by Application
8.2.1 China Antiretroviral Therapy Sales by Application (2018-2029)
8.2.2 China Antiretroviral Therapy Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Antiretroviral Therapy Market Size by Type
9.1.1 Asia Antiretroviral Therapy Sales by Type (2018-2029)
9.1.2 Asia Antiretroviral Therapy Revenue by Type (2018-2029)
9.2 Asia Antiretroviral Therapy Market Size by Application
9.2.1 Asia Antiretroviral Therapy Sales by Application (2018-2029)
9.2.2 Asia Antiretroviral Therapy Revenue by Application (2018-2029)
9.3 Asia Antiretroviral Therapy Sales by Region
9.3.1 Asia Antiretroviral Therapy Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Antiretroviral Therapy Revenue by Region (2018-2029)
9.3.3 Asia Antiretroviral Therapy Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Antiretroviral Therapy Market Size by Type
10.1.1 Middle East, Africa and Latin America Antiretroviral Therapy Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Antiretroviral Therapy Market Size by Application
10.2.1 Middle East, Africa and Latin America Antiretroviral Therapy Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Antiretroviral Therapy Sales by Country
10.3.1 Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Antiretroviral Therapy Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Gilead
11.1.1 Gilead Company Information
11.1.2 Gilead Overview
11.1.3 Gilead Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Gilead Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Gilead Recent Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Information
11.2.2 F. Hoffmann-La Roche Overview
11.2.3 F. Hoffmann-La Roche Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 F. Hoffmann-La Roche Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 F. Hoffmann-La Roche Recent Developments
11.3 ViiV Healthcare
11.3.1 ViiV Healthcare Company Information
11.3.2 ViiV Healthcare Overview
11.3.3 ViiV Healthcare Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 ViiV Healthcare Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 ViiV Healthcare Recent Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Information
11.4.2 Boehringer Ingelheim Overview
11.4.3 Boehringer Ingelheim Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Boehringer Ingelheim Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Boehringer Ingelheim Recent Developments
11.5 Janssen Pharmaceuticals
11.5.1 Janssen Pharmaceuticals Company Information
11.5.2 Janssen Pharmaceuticals Overview
11.5.3 Janssen Pharmaceuticals Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Janssen Pharmaceuticals Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Janssen Pharmaceuticals Recent Developments
11.6 Mylan
11.6.1 Mylan Company Information
11.6.2 Mylan Overview
11.6.3 Mylan Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Mylan Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Mylan Recent Developments
11.7 Abbvie
11.7.1 Abbvie Company Information
11.7.2 Abbvie Overview
11.7.3 Abbvie Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Abbvie Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Abbvie Recent Developments
11.8 Bionor Pharma
11.8.1 Bionor Pharma Company Information
11.8.2 Bionor Pharma Overview
11.8.3 Bionor Pharma Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Bionor Pharma Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bionor Pharma Recent Developments
11.9 Vertex Pharmaceuticals
11.9.1 Vertex Pharmaceuticals Company Information
11.9.2 Vertex Pharmaceuticals Overview
11.9.3 Vertex Pharmaceuticals Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Vertex Pharmaceuticals Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Vertex Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antiretroviral Therapy Industry Chain Analysis
12.2 Antiretroviral Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antiretroviral Therapy Production Mode & Process
12.4 Antiretroviral Therapy Sales and Marketing
12.4.1 Antiretroviral Therapy Sales Channels
12.4.2 Antiretroviral Therapy Distributors
12.5 Antiretroviral Therapy Customers
13 Market Dynamics
13.1 Antiretroviral Therapy Industry Trends
13.2 Antiretroviral Therapy Market Drivers
13.3 Antiretroviral Therapy Market Challenges
13.4 Antiretroviral Therapy Market Restraints
14 Key Findings in The Global Antiretroviral Therapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Antiretroviral Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of NNRTIs
Table 3. Major Manufacturers of NRTI
Table 4. Major Manufacturers of Multiclass Combination Products
Table 5. Major Manufacturers of Integrase Inhibitors
Table 6. Global Antiretroviral Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Antiretroviral Therapy Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Antiretroviral Therapy Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Antiretroviral Therapy Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Antiretroviral Therapy Revenue Market Share by Region (2018-2024)
Table 11. Global Antiretroviral Therapy Revenue Market Share by Region (2024-2029)
Table 12. Global Antiretroviral Therapy Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Antiretroviral Therapy Sales by Region (2018-2024) & (KG)
Table 14. Global Antiretroviral Therapy Sales by Region (2024-2029) & (KG)
Table 15. Global Antiretroviral Therapy Sales Market Share by Region (2018-2024)
Table 16. Global Antiretroviral Therapy Sales Market Share by Region (2024-2029)
Table 17. Global Antiretroviral Therapy Sales by Manufacturers (2018-2024) & (KG)
Table 18. Global Antiretroviral Therapy Sales Share by Manufacturers (2018-2024)
Table 19. Global Antiretroviral Therapy Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Antiretroviral Therapy Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Antiretroviral Therapy, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Antiretroviral Therapy Price by Manufacturers 2018-2024 (US$/KG)
Table 23. Global Antiretroviral Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Antiretroviral Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiretroviral Therapy as of 2022)
Table 25. Global Key Manufacturers of Antiretroviral Therapy, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Antiretroviral Therapy, Product Offered and Application
Table 27. Global Key Manufacturers of Antiretroviral Therapy, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Antiretroviral Therapy Sales by Type (2018-2024) & (KG)
Table 30. Global Antiretroviral Therapy Sales by Type (2024-2029) & (KG)
Table 31. Global Antiretroviral Therapy Sales Share by Type (2018-2024)
Table 32. Global Antiretroviral Therapy Sales Share by Type (2024-2029)
Table 33. Global Antiretroviral Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Antiretroviral Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Antiretroviral Therapy Revenue Share by Type (2018-2024)
Table 36. Global Antiretroviral Therapy Revenue Share by Type (2024-2029)
Table 37. Antiretroviral Therapy Price by Type (2018-2024) & (US$/KG)
Table 38. Global Antiretroviral Therapy Price Forecast by Type (2024-2029) & (US$/KG)
Table 39. Global Antiretroviral Therapy Sales by Application (2018-2024) & (KG)
Table 40. Global Antiretroviral Therapy Sales by Application (2024-2029) & (KG)
Table 41. Global Antiretroviral Therapy Sales Share by Application (2018-2024)
Table 42. Global Antiretroviral Therapy Sales Share by Application (2024-2029)
Table 43. Global Antiretroviral Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Antiretroviral Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Antiretroviral Therapy Revenue Share by Application (2018-2024)
Table 46. Global Antiretroviral Therapy Revenue Share by Application (2024-2029)
Table 47. Antiretroviral Therapy Price by Application (2018-2024) & (US$/KG)
Table 48. Global Antiretroviral Therapy Price Forecast by Application (2024-2029) & (US$/KG)
Table 49. US & Canada Antiretroviral Therapy Sales by Type (2018-2024) & (KG)
Table 50. US & Canada Antiretroviral Therapy Sales by Type (2024-2029) & (KG)
Table 51. US & Canada Antiretroviral Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Antiretroviral Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Antiretroviral Therapy Sales by Application (2018-2024) & (KG)
Table 54. US & Canada Antiretroviral Therapy Sales by Application (2024-2029) & (KG)
Table 55. US & Canada Antiretroviral Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Antiretroviral Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Antiretroviral Therapy Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Antiretroviral Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Antiretroviral Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Antiretroviral Therapy Sales by Country (2018-2024) & (KG)
Table 61. US & Canada Antiretroviral Therapy Sales by Country (2024-2029) & (KG)
Table 62. Europe Antiretroviral Therapy Sales by Type (2018-2024) & (KG)
Table 63. Europe Antiretroviral Therapy Sales by Type (2024-2029) & (KG)
Table 64. Europe Antiretroviral Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Antiretroviral Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Antiretroviral Therapy Sales by Application (2018-2024) & (KG)
Table 67. Europe Antiretroviral Therapy Sales by Application (2024-2029) & (KG)
Table 68. Europe Antiretroviral Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Antiretroviral Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Antiretroviral Therapy Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Antiretroviral Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Antiretroviral Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Antiretroviral Therapy Sales by Country (2018-2024) & (KG)
Table 74. Europe Antiretroviral Therapy Sales by Country (2024-2029) & (KG)
Table 75. China Antiretroviral Therapy Sales by Type (2018-2024) & (KG)
Table 76. China Antiretroviral Therapy Sales by Type (2024-2029) & (KG)
Table 77. China Antiretroviral Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Antiretroviral Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Antiretroviral Therapy Sales by Application (2018-2024) & (KG)
Table 80. China Antiretroviral Therapy Sales by Application (2024-2029) & (KG)
Table 81. China Antiretroviral Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Antiretroviral Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Antiretroviral Therapy Sales by Type (2018-2024) & (KG)
Table 84. Asia Antiretroviral Therapy Sales by Type (2024-2029) & (KG)
Table 85. Asia Antiretroviral Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Antiretroviral Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Antiretroviral Therapy Sales by Application (2018-2024) & (KG)
Table 88. Asia Antiretroviral Therapy Sales by Application (2024-2029) & (KG)
Table 89. Asia Antiretroviral Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Antiretroviral Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Antiretroviral Therapy Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Antiretroviral Therapy Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Antiretroviral Therapy Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Antiretroviral Therapy Sales by Region (2018-2024) & (KG)
Table 95. Asia Antiretroviral Therapy Sales by Region (2024-2029) & (KG)
Table 96. Middle East, Africa and Latin America Antiretroviral Therapy Sales by Type (2018-2024) & (KG)
Table 97. Middle East, Africa and Latin America Antiretroviral Therapy Sales by Type (2024-2029) & (KG)
Table 98. Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Antiretroviral Therapy Sales by Application (2018-2024) & (KG)
Table 101. Middle East, Africa and Latin America Antiretroviral Therapy Sales by Application (2024-2029) & (KG)
Table 102. Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Antiretroviral Therapy Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Antiretroviral Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Antiretroviral Therapy Sales by Country (2018-2024) & (KG)
Table 108. Middle East, Africa and Latin America Antiretroviral Therapy Sales by Country (2024-2029) & (KG)
Table 109. Gilead Company Information
Table 110. Gilead Description and Major Businesses
Table 111. Gilead Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2018-2024)
Table 112. Gilead Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Gilead Recent Developments
Table 114. F. Hoffmann-La Roche Company Information
Table 115. F. Hoffmann-La Roche Description and Major Businesses
Table 116. F. Hoffmann-La Roche Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2018-2024)
Table 117. F. Hoffmann-La Roche Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. F. Hoffmann-La Roche Recent Developments
Table 119. ViiV Healthcare Company Information
Table 120. ViiV Healthcare Description and Major Businesses
Table 121. ViiV Healthcare Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2018-2024)
Table 122. ViiV Healthcare Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. ViiV Healthcare Recent Developments
Table 124. Boehringer Ingelheim Company Information
Table 125. Boehringer Ingelheim Description and Major Businesses
Table 126. Boehringer Ingelheim Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2018-2024)
Table 127. Boehringer Ingelheim Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Boehringer Ingelheim Recent Developments
Table 129. Janssen Pharmaceuticals Company Information
Table 130. Janssen Pharmaceuticals Description and Major Businesses
Table 131. Janssen Pharmaceuticals Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2018-2024)
Table 132. Janssen Pharmaceuticals Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Janssen Pharmaceuticals Recent Developments
Table 134. Mylan Company Information
Table 135. Mylan Description and Major Businesses
Table 136. Mylan Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2018-2024)
Table 137. Mylan Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Mylan Recent Developments
Table 139. Abbvie Company Information
Table 140. Abbvie Description and Major Businesses
Table 141. Abbvie Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2018-2024)
Table 142. Abbvie Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Abbvie Recent Developments
Table 144. Bionor Pharma Company Information
Table 145. Bionor Pharma Description and Major Businesses
Table 146. Bionor Pharma Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2018-2024)
Table 147. Bionor Pharma Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Bionor Pharma Recent Developments
Table 149. Vertex Pharmaceuticals Company Information
Table 150. Vertex Pharmaceuticals Description and Major Businesses
Table 151. Vertex Pharmaceuticals Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2018-2024)
Table 152. Vertex Pharmaceuticals Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Vertex Pharmaceuticals Recent Developments
Table 154. Key Raw Materials Lists
Table 155. Raw Materials Key Suppliers Lists
Table 156. Antiretroviral Therapy Distributors List
Table 157. Antiretroviral Therapy Customers List
Table 158. Antiretroviral Therapy Market Trends
Table 159. Antiretroviral Therapy Market Drivers
Table 160. Antiretroviral Therapy Market Challenges
Table 161. Antiretroviral Therapy Market Restraints
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiretroviral Therapy Product Picture
Figure 2. Global Antiretroviral Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Antiretroviral Therapy Market Share by Type in 2022 & 2029
Figure 4. NNRTIs Product Picture
Figure 5. NRTI Product Picture
Figure 6. Multiclass Combination Products Product Picture
Figure 7. Integrase Inhibitors Product Picture
Figure 8. Global Antiretroviral Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Antiretroviral Therapy Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Other
Figure 13. Antiretroviral Therapy Report Years Considered
Figure 14. Global Antiretroviral Therapy Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Antiretroviral Therapy Revenue 2018-2029 (US$ Million)
Figure 16. Global Antiretroviral Therapy Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Antiretroviral Therapy Revenue Market Share by Region (2018-2029)
Figure 18. Global Antiretroviral Therapy Sales 2018-2029 ((KG)
Figure 19. Global Antiretroviral Therapy Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Antiretroviral Therapy Sales YoY (2018-2029) & (KG)
Figure 21. US & Canada Antiretroviral Therapy Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Antiretroviral Therapy Sales YoY (2018-2029) & (KG)
Figure 23. Europe Antiretroviral Therapy Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Antiretroviral Therapy Sales YoY (2018-2029) & (KG)
Figure 25. China Antiretroviral Therapy Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Antiretroviral Therapy Sales YoY (2018-2029) & (KG)
Figure 27. Asia (excluding China) Antiretroviral Therapy Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Antiretroviral Therapy Sales YoY (2018-2029) & (KG)
Figure 29. Middle East, Africa and Latin America Antiretroviral Therapy Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Antiretroviral Therapy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Antiretroviral Therapy in the World: Market Share by Antiretroviral Therapy Revenue in 2022
Figure 32. Global Antiretroviral Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Antiretroviral Therapy Sales Market Share by Type (2018-2029)
Figure 34. Global Antiretroviral Therapy Revenue Market Share by Type (2018-2029)
Figure 35. Global Antiretroviral Therapy Sales Market Share by Application (2018-2029)
Figure 36. Global Antiretroviral Therapy Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Antiretroviral Therapy Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Antiretroviral Therapy Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Antiretroviral Therapy Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Antiretroviral Therapy Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Antiretroviral Therapy Revenue Share by Country (2018-2029)
Figure 42. US & Canada Antiretroviral Therapy Sales Share by Country (2018-2029)
Figure 43. U.S. Antiretroviral Therapy Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Antiretroviral Therapy Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Antiretroviral Therapy Sales Market Share by Type (2018-2029)
Figure 46. Europe Antiretroviral Therapy Revenue Market Share by Type (2018-2029)
Figure 47. Europe Antiretroviral Therapy Sales Market Share by Application (2018-2029)
Figure 48. Europe Antiretroviral Therapy Revenue Market Share by Application (2018-2029)
Figure 49. Europe Antiretroviral Therapy Revenue Share by Country (2018-2029)
Figure 50. Europe Antiretroviral Therapy Sales Share by Country (2018-2029)
Figure 51. Germany Antiretroviral Therapy Revenue (2018-2029) & (US$ Million)
Figure 52. France Antiretroviral Therapy Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Antiretroviral Therapy Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Antiretroviral Therapy Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Antiretroviral Therapy Revenue (2018-2029) & (US$ Million)
Figure 56. China Antiretroviral Therapy Sales Market Share by Type (2018-2029)
Figure 57. China Antiretroviral Therapy Revenue Market Share by Type (2018-2029)
Figure 58. China Antiretroviral Therapy Sales Market Share by Application (2018-2029)
Figure 59. China Antiretroviral Therapy Revenue Market Share by Application (2018-2029)
Figure 60. Asia Antiretroviral Therapy Sales Market Share by Type (2018-2029)
Figure 61. Asia Antiretroviral Therapy Revenue Market Share by Type (2018-2029)
Figure 62. Asia Antiretroviral Therapy Sales Market Share by Application (2018-2029)
Figure 63. Asia Antiretroviral Therapy Revenue Market Share by Application (2018-2029)
Figure 64. Asia Antiretroviral Therapy Revenue Share by Region (2018-2029)
Figure 65. Asia Antiretroviral Therapy Sales Share by Region (2018-2029)
Figure 66. Japan Antiretroviral Therapy Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Antiretroviral Therapy Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Antiretroviral Therapy Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Antiretroviral Therapy Revenue (2018-2029) & (US$ Million)
Figure 70. India Antiretroviral Therapy Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Antiretroviral Therapy Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Antiretroviral Therapy Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Antiretroviral Therapy Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Antiretroviral Therapy Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Antiretroviral Therapy Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Antiretroviral Therapy Sales Share by Country (2018-2029)
Figure 77. Brazil Antiretroviral Therapy Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Antiretroviral Therapy Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Antiretroviral Therapy Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Antiretroviral Therapy Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Antiretroviral Therapy Revenue (2018-2029) & (US$ Million)
Figure 82. Antiretroviral Therapy Value Chain
Figure 83. Antiretroviral Therapy Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed